Evidence map›Paper›PMID 23044338›Full record

ArticleCell transplantation2013

Imaging neural stem cell graft-induced structural repair in stroke.

Marcel M Daadi, Shijun Hu, Jill Klausner, Zongjin Li, Marc Sofilos, Guohua Sun, Joseph C Wu, Gary K Steinberg

Open access · greenAbstract read
In one paragraph

Article in Cell transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Review
  9. Review
  10. Review
  11. Review
  12. Theranostics · 2018
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marcel M DaadiDepartment of Neurosurgery, Stanford Stroke Center and Stanford Institute for Neuro-Innovationand Translational Neurosciences, Stanford, CA, USA. mdaadi@stanford.edu
Shijun Hu
Jill Klausner
Zongjin Li
Marc Sofilos
Guohua Sun
Joseph C Wu
Gary K Steinberg
Stanford Medicine · USStanford University · US

Funding

Transgenic animal injury paradigmsP01NS037520 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 1999 to 2008
$10.8M
Paracrine and synaptic mechanisms underlying recovery using human stem cell theraR01NS058784 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 2008 to 2023
$6.6M
NMDA ANTAGONISTS IN THE TREATMENT OF STROKER01NS027292 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 1991 to 2009
$3.7M
NINDS NIH HHS P01 NS037520NINDS NIH HHS P01 NS37520NINDS NIH HHS R01 NS027292NINDS NIH HHS R01 NS058784NINDS NIH HHS R01 NS27292
6 · The paper itself

Abstract

Stem cell therapy ameliorates motor deficits in experimental stroke model. Multimodal molecular imaging enables real-time longitudinal monitoring of infarct location, size, and transplant survival. In the present study, we used magnetic resonance imaging (MRI) and positron emission tomography (PET) to track the infarct evolution,tissue repair, and the fate of grafted cells. We genetically engineered embryonic stem cell-derived neural stem cells (NSCs) with a triple fusion reporter gene to express monomeric red fluorescence protein and herpes simplex virus-truncated thymidine kinase for multimodal molecular imaging and SPIO labeled for MRI. The infarct size as well as fate and function of grafted cells were tracked in real time for 3 months using MRI and PET. We report that grafted NSCs reduced the infarct size in animals with less than 0.1 cm(3) initial infarct in a dose-dependent manner, while larger stroke was not amenable to such beneficial effects. PET imaging revealed increased metabolic activity in grafted animals and visualized functioning grafted cells in vivo. Immunohistopathological analysis demonstrated that, after a 3-month survival period, grafted NSCs dispersed in the stroke-lesioned parenchyma and differentiated into neurons, astrocytes, and oligodendrocytes. Longitudinal multimodal imaging provides insights into time course dose-dependent interactions between NSC grafts and structural changes in infarcted tissue.

Indexed as

AnimalsCell DifferentiationCell LineageEmbryonic Stem CellsFerric CompoundsHumansLentivirusMagnetic Resonance ImagingMaleNeural Stem CellsPositron-Emission TomographyProtein-Tyrosine KinasesRadiographyRatsRats, Sprague-DawleyStrokeFerric Compoundsferric oxideProtein-Tyrosine Kinases

Identifiers

PMID23044338
PMCPMC5823270
OpenAlexW2332111100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.